SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-107257
Filing Date
2010-05-05
Accepted
2010-05-05 06:02:46
Documents
7
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 323426
2 FORM OF EXECUTIVE RETENTION AGREEMENT dex101.htm EX-10.1 79778
3 FORM OF AMENDMENT TO FORM OF EXECUTIVE RETENTION AGREEMENT dex102.htm EX-10.2 13830
4 AMENDMENT TO LEASE AGREEMENT, DATED FEBRUARY 12, 2010 dex104.htm EX-10.4 19068
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9708
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9909
7 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 5201
  Complete submission text file 0001193125-10-107257.txt   462283
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 10799447
SIC: 2835 In Vitro & In Vivo Diagnostic Substances